Ahead of Fed Reserve''s decision on interest rates, stocks traded in a lackluster fashion. The Dow and S&P 500 traded below the flat line, while the Nasdaq showed strength. The worst performers were pharmaceutical stocks, dragged largely by AstraZeneca, down 2.9%. Biopharnmaceutical company Encysive tumbled 46.5%. Energy stocks were under pressure on lower oil prices, while airline stocks benefited from the decline. Housing and gold stocks were notable gainers. |
More:
